Keragon: Turning Data Chaos into Clinical Confidence
What is Keragon? Keragon is an AI-driven clinical decision support platform designed to optimise diagnostic accuracy, treatment planning, and workflow prioritisation in hospital and outpatient settings. It ingests structured and unstructured patient data — including EHR records, lab results, imaging summaries, and vital signs — to generate real-time recommendations for clinicians. The system offers differential […]
Feature Categories
What is Keragon?
Keragon is an AI-driven clinical decision support platform designed to optimise diagnostic accuracy, treatment planning, and workflow prioritisation in hospital and outpatient settings. It ingests structured and unstructured patient data — including EHR records, lab results, imaging summaries, and vital signs — to generate real-time recommendations for clinicians. The system offers differential diagnosis support, risk stratification, alerts for critical conditions, and evidence-based treatment pathways.
Keragon’s interface allows seamless integration into clinician workflows, providing concise, actionable insights while reducing alert fatigue. The platform is continuously updated with peer-reviewed literature and guideline changes, supporting multi-specialty care from internal medicine and cardiology to emergency medicine.
Why Leading Healthcare Teams Trust Keragon
- Holds both SOC 2 Type 2 and HIPAA compliance certifications from external auditors, demonstrating verified security standards
- Implements AES-256 encryption for data both at rest and in transit, along with secure single sign-on and two-factor authentication
- Enforces a strict seven-day data retention policy, automatically deleting all customer workflow data after this period to protect patient privacy
- Provides Business Associate Agreements on all paid plans and maintains comprehensive audit trails for regulatory compliance
- Raised $7.5 million in seed funding led by Upfront Ventures in February 2025, bringing total funding to $10.5 million
- Initial $3 million pre-seed round was co-led by Focal and Afore Capital, with participation from 25madison and Lifepoint Health
- Founded by four second-time entrepreneurs whose previous startup (Avocarrot) was acquired by Glispa for $20 million, bringing proven execution experience
- Surpassed 100 paying customers within six months of launch with 30% month-over-month growth and over 2 million workflow automations executed
- Supports integration with over 300 healthcare tools and software platforms, demonstrating extensive ecosystem compatibility
- Customer case study shows Women's Mental Health Specialists reduced administrative work by five hours weekly and achieved 15% revenue increase
Top 3 Pain Points Keragon Fixes in Healthcare
| Problem | How Keragon Solves It |
|---|---|
| 1. Delayed or Inconsistent Clinical Decisions | Provides real-time, evidence-based recommendations and alerts, reducing variability and speeding diagnostic and treatment decisions. |
| 2. Difficulty Integrating Multimodal Patient Data | Aggregates EHR data, labs, imaging, vitals, and unstructured notes into a unified clinical view for actionable insights. |
| 3. Risk of Missed Critical Events | Offers predictive alerts for acute conditions (e.g., sepsis, heart failure) to proactively guide clinician interventions and prevent adverse outcomes. |
Feature Category Summary: Keragon
| Feature Category | Summary | Association (YES, NO, NA) |
|---|---|---|
| Regulatory-Ready | Keragon positions itself as a secure, HIPAA-compliant automation platform with SOC 2 Type II certification and auditability of workflows, but there is no explicit evidence of FDA/EMA clearance, GxP validation, or use as a regulated medical device/clinical decision support system of record. | NA |
| Clinical Trial Support | Use cases emphasize automating operational workflows such as referrals, prior authorizations, intake, billing, and patient communications; there is no public documentation that Keragon provides specific functionality for clinical trial design, patient recruitment to trials, protocol monitoring, or trial reporting. | NA |
| Supply Chain & Quality | Keragon connects EHRs, CRMs, billing, labs, and communication tools to automate healthcare workflows, but there is no indication of dedicated features for drug or device manufacturing integrity, serialization, counterfeit detection, or broader supply chain quality management. | NA |
| Efficiency & Cost-Saving | Marketing and third‑party overviews state that Keragon automates repetitive administrative and clinical workflows, reduces manual steps, and can reduce admin work by around 30 percent and referral follow‑ups by 65 percent, enabling staff to save time and focus more on patient care. | YES |
| Scalable / Enterprise-Grade | Keragon is described as a no‑code automation platform built specifically for healthcare, trusted by 100+ clinics, integrating with 200–300+ healthcare tools including many EHRs, and built on a robust SOC 2 Type II‑certified infrastructure, which supports positioning as an enterprise-capable SaaS platform, though not specifically in pharma/biotech. | YES |
| HIPAA Compliant | Keragon explicitly states that the platform is fully HIPAA‑compliant, is marketed as a HIPAA‑compliant alternative to generic automation tools, and offers signed Business Associate Agreements (BAAs) on paid plans for handling PHI. | YES |
| Clinically Validated | Public materials focus on workflow automation and operational efficiency; there is no evidence of clinical validation studies demonstrating impact on diagnostic accuracy, patient outcomes, or safety as a clinical decision support or medical AI system. | NA |
| EHR Integration | Keragon highlights healthcare‑specific integrations with numerous EHR systems (for example athenahealth, eClinicalWorks, DrChrono, Elation, Canvas Medical, Practice EHR and others) and is promoted as connecting 100+ to 300+ EHRs and related tools to synchronize data and automate EHR workflows. | YES |
| Explainable AI | Keragon uses AI “copilot” capabilities to help build no‑code workflows and publishes thought leadership on AI ethics, but there is no documentation that the platform provides algorithm‑level explainability for clinical predictions (for example feature importance, rationale for AI recommendations) within clinical decision support contexts. | NA |
| Real-Time Analytics | Descriptions mention real‑time data synchronization and triggering of workflows (for example lab results alerts, routing of meeting transcripts, continuous syncing between EHRs and other systems), indicating near real‑time processing of events and data across integrated tools. | YES |
| Bias Detection | Keragon’s blog discusses algorithmic bias and HIPAA risks in AI and emphasizes the need to monitor AI performance for emerging risks or biases, but there is no explicit feature description of built‑in bias detection, fairness metrics, or demographic bias dashboards within the Keragon platform itself. | NA |
| Ethical Safeguards | Thought‑leadership articles from Keragon address ethical issues in AI, HIPAA risks, accountability, and the importance of monitoring AI performance and mitigating bias, yet product descriptions do not specify configurable consent management modules, human‑in‑the‑loop override controls for AI recommendations, or formal use‑case restriction governance inside the platform. | NA |
Risks & Limitations: Keragon
-
Predictive performance depends on data quality and completeness; missing or inconsistent data can reduce accuracy.
-
Outputs are decision-support only; clinicians must validate recommendations.
-
Integration with proprietary EHR or operational systems may require IT effort and workflow mapping.
-
Regulatory or compliance review may be needed if outputs are used for clinical trial design, patient recruitment, or treatment automation.
-
Overreliance may reduce clinician critical appraisal; recommended to use as complementary support alongside clinical judgment.
Share This AI Tool
Get a neutral, no obligation view of whether this AI tool fits your portfolio
